Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) has been given an average rating of "Moderate Buy" by the six ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $25.75.
A number of equities research analysts have weighed in on the company. BTIG Research lifted their price objective on Shoulder Innovations from $26.00 to $27.00 and gave the company a "buy" rating in a report on Monday, October 12th. Piper Sandler reaffirmed an "overweight" rating and issued a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. UBS Group upped their price target on Shoulder Innovations from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Monday, August 10th. Finally, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Shoulder Innovations in a report on Friday, October 30th.
Check Out Our Latest Report on Shoulder Innovations
Shoulder Innovations Price Performance
NYSE:SI opened at $20.65 on Thursday. The company has a 50-day moving average of $19.10 and a 200-day moving average of $17.44. The company has a market capitalization of $432.00 million, a price-to-earnings ratio of -12.75 and a beta of -1.51. Shoulder Innovations has a 52 week low of $12.00 and a 52 week high of $24.59. The company has a debt-to-equity ratio of 0.13, a quick ratio of 8.69 and a current ratio of 10.68.
Shoulder Innovations (NYSE:SI - Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported ($0.34) earnings per share for the quarter, beating analysts' consensus estimates of ($0.49) by $0.15. Shoulder Innovations had a negative net margin of 51.72% and a negative return on equity of 25.37%. The business had revenue of $16.19 million for the quarter. As a group, equities research analysts anticipate that Shoulder Innovations will post -1.70 earnings per share for the current fiscal year.
Insider Activity
In other news, CEO Robert Ball sold 10,175 shares of the business's stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $18.45, for a total value of $187,728.75. Following the transaction, the chief executive officer directly owned 380,824 shares of the company's stock, valued at $7,026,202.80. The trade was a 2.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $22.60, for a total value of $27,029.60. Following the sale, the insider owned 2,185,914 shares in the company, valued at approximately $49,401,656.40. This trade represents a 0.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,568 shares of company stock worth $694,029 over the last ninety days. Insiders own 29.00% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in SI. Compass Financial Management LLC acquired a new position in shares of Shoulder Innovations during the second quarter worth approximately $30,000. Integrated Wealth Concepts LLC bought a new position in Shoulder Innovations in the 2nd quarter worth approximately $35,000. China Universal Asset Management Co. Ltd. raised its position in Shoulder Innovations by 28.0% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 6,400 shares of the company's stock worth $120,000 after purchasing an additional 1,400 shares during the last quarter. Jump Financial LLC lifted its holdings in Shoulder Innovations by 27.4% during the 3rd quarter. Jump Financial LLC now owns 17,222 shares of the company's stock worth $325,000 after buying an additional 3,702 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in Shoulder Innovations during the 1st quarter worth $252,000.
About Shoulder Innovations
(
Get Free Report)
Shoulder Innovations, Inc. is a medical technology company focused on developing and commercializing products for shoulder replacement surgery. Its offerings are designed for orthopedic surgeons treating patients with shoulder conditions that may require joint replacement. The company's product portfolio includes shoulder implant systems such as its InSet glenoid and Catalyst reverse shoulder technologies, along with related surgical instruments. These products support different approaches to shoulder arthroplasty, including procedures that replace or reconstruct parts of the shoulder joint.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Shoulder Innovations, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.
While Shoulder Innovations currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.